Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

Edwards Expects Up To $190 Million In Transcatheter Valve Sales In 2010

This article was originally published in The Gray Sheet

  • News

Executive Summary

Edwards LifeSciences estimates sales of its Sapien transcatheter aortic heart valve will be in the range of $170 million to $190 million in 2010, the company said during its Dec. 10 investor day at its Irvine, Calif., headquarters

You may also be interested in...



Edwards: Surgical Valve Sales Slow As Transcatheter Valve Ramps Up

Growth in Edwards Lifesciences surgical heart valve sales slowed in the first quarter due in part to pricing missteps, while the firm's nascent transcatheter heart valve business continued to pick up steam

Edwards: Surgical Valve Sales Slow As Transcatheter Valve Ramps Up

Growth in Edwards Lifesciences surgical heart valve sales slowed in the first quarter due in part to pricing missteps, while the firm's nascent transcatheter heart valve business continued to pick up steam

Edwards Looks To Smaller-Diameter Transcatheter Valve In 2010

Edwards Lifesciences hopes to overcome one of its biggest competitive disadvantages in the European transcatheter valve market early next year with the planned launch of a smaller-profile product

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion

Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations

See All
UsernamePublicRestriction

Register

MT028269

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By